ASTELLAS PHARMA, INC. (ALPMF)
Clinical trial NCT03971253 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-05-31 → 2026-05-29 3. primary completion date: 2026-05-31 → 2026-05-29 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT03971253 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-05-31 → 2026-05-29 3. primary completion date: 2026-05-31 → 2026-05-29 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT01224795 updates: 1. status: TERMINATED → WITHDRAWN 2. enrollment: 1 → 0 participants
Clinical trial NCT06835569: enrollment: 188 → 448 participants.
Clinical trial NCT07190794 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2026-06-01 → 2026-05-28 3. primary completion date: 2026-06-01 → 2026-05-28 4. enrollment: 150 → 18 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07111988: start date: 2026-05-01 → 2026-06-01.
Clinical trial NCT07298434: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Clinical trial NCT06318286 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2026-04-30 → 2026-06-30
Clinical trial NCT06706817 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 180 → 181 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07455825 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-03 → 2026-06-01 3. primary completion date: 2026-06-03 → 2026-06-01
Clinical trial NCT07044336 updates: 1. primary completion date: 2028-01-20 → 2027-10-15 2. enrollment: 700 → 800 participants